Skip to main content
Clinical Trials/NCT02389569
NCT02389569
Completed
N/A

A Prospective, Double-blind, Randomized, Group Controlled Clinical Study on the Use of Biosilicate Under Resin Composite Restorations in Caries Affected Teeth

University of Sao Paulo1 site in 1 country66 target enrollmentMarch 17, 2015
ConditionsDental Caries

Overview

Phase
N/A
Intervention
Not specified
Conditions
Dental Caries
Sponsor
University of Sao Paulo
Enrollment
66
Locations
1
Primary Endpoint
Clinical performance of Biosilicate in caries lesion using FDI evaluation criteria
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

This study aimed to evaluate the clinical performance of a novel vitro-ceramic biomaterial (Biosilicate®) as treatment of caries-affected dentin in posterior resin restorations. A total of 94 restorations of 66 participants were selected and assigned at random into four groups: 1 (Biosilicate / Two-step etch and rinse system), 2 (Control / Two-step etch and rinse system), 3 (Biosilicate / Two-step self-etching system) and 4 (Control / Two-step self-etching system). Two operators carried out the adhesive protocols and restored the cavities with a nano-hybrid resin composite (IPS Empress, Ivoclar) using the incremental technique. Participants were recalled at one week, 6, 12 and 18 months for clinical evaluation performed by two blinders and calibrated examiners according FDI criteria.

Detailed Description

Background: Dental caries has decreased in recent years, but is still the main oral health problem in developed and undeveloped industrialized countries. The purpose of this study is to evaluate clinical performance of resin-based composite Class I and II restorations in association with Biosilicate. Methods: Eighty patients with carious lesions will be receive restorations in premolars and molars, which will be randomly allocated in four experimental groups: G1 (Biosilicate, AdperSingle Bond 2 and IPS Empress Direct composite), G2 (Adper Single Bond 2 and IPS Empress Direct composite), G3 (Biosilicate, AdheSe and IPS Empress Direct composite) e G4 (AdheSE and IPS Empress Direct composite) To participate in the clinical trial, qualified subjects must meet for inclusion and exclusion criteria. Sixty-four (64) selected volunteers will be fully informed on the nature of the study and after had signed a Term of Acceptance defined by the Ethics Committee (FORP - USP), they will be invited to participate. Carious teeth will be cleaned with a pumice-water slurry and rubber cup to remove salivary pellicle and any bacterial plaque. As much as possible, local anesthesia will be. After caries removal (high and low-speed handpieces under abundant water irrigation), patients will be allocated randomly in the four experimental groups cited above. Final contouring and polishing of the restorations will be performed at the same appointment, using a fine-grit diamond bur (KG Sorensen), silicon carbide polisher (Viking Kit, KG Sorensen), silicone rubber tips (Viking Kit, KG Sorensen) flexible discs (Sof-Lex, 3M ESPE), and polishing pastes (Diamond Excel, FGM). Two trained and calibrated evaluators, fully blinded to the restorative techniques used, will be evaluating the restorations at baseline (one week after placement of restorations), after 06, 12 and 18 months using FDI criteria. All restorations will be photographed at every evaluation point. Esthetic, Functional and Biological proprieties will be used as key parameters determining the overall clinical success. Data will be analyzed.

Registry
clinicaltrials.gov
Start Date
March 17, 2015
End Date
August 1, 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Factorial
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Karen Pintado Palomino

MSc

University of Sao Paulo

Eligibility Criteria

Inclusion Criteria

  • Cavitated or non-cavitated active carious lesions in dentin (Class I and/or II)
  • Carious lesion in teeth with or without restoration in at least one tooth (upper or lower premolar and/or molar).
  • No history of spontaneous pain
  • Pulp vital tests positive
  • No evidence of periapical radiolucency

Exclusion Criteria

  • Compromised medical history
  • Periodontal disease
  • Pulp necrosis
  • Absence of antagonist teeth
  • Severe bruxism
  • Active orthodontic treatment
  • Teeth with cracks and premature contact.
  • Pregnancy

Outcomes

Primary Outcomes

Clinical performance of Biosilicate in caries lesion using FDI evaluation criteria

Time Frame: 18 months

Two experienced and calibrated dentists, not involved with the placement of the restorations will be assess the efficiency of Biosilicate under composite restoration of Class I and Class II dentin caries lesions by record instrument to record the esthetic, functional and biological properties over a 18 months time frame. These variables will be ranked according to the FDI criteria in the following scores: clinically very good, clinically good, clinically sufficient/ satisfactory, clinically unsatisfactory and clinically poor.

Study Sites (1)

Loading locations...

Similar Trials